Cargando…

Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form

Antiphospholipid syndrome (APS) is a multisystem autoimmune disease most commonly associated with recurrent arterial and venous thromboembolism and recurrent fetal loss. Other possible antiphospholipid antibody (aPL)-related clinical manifestations include cardiac involvement. The heart can be invol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolitz, Tamara, Shiber, Shachaf, Sharabi, Itzhak, Winder, Asher, Zandman-Goddard, Gisele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522847/ https://www.ncbi.nlm.nih.gov/pubmed/31134062 http://dx.doi.org/10.3389/fimmu.2019.00941

Ejemplares similares

Adult-onset Still's disease following mRNA COVID-19 vaccination
por: Sharabi, Amir, et al.
Publicado: (2021)

Prolactin and Autoimmunity
por: Borba, Vânia Vieira, et al.
Publicado: (2018)

The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
por: Rosário, Cristina, et al.
Publicado: (2013)

Editorial: Primary Antiphospholipid Syndrome
por: Serrano, Antonio, et al.
Publicado: (2020)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

A Review of Cardiac Manifestations in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome With Focus on Endocarditis
por: Tayem, Matthew G, et al.
Publicado: (2022)

Malignant Isolated Cortical Vein Thrombosis as the Initial Manifestation of Primary Antiphospholipid Syndrome: Lessons on Diagnosis and Management From a Case Report
por: Shen, Jie, et al.
Publicado: (2022)

Primary Immunodeficiencies With Defects in Innate Immunity: Focus on Orofacial Manifestations
por: Jung, Sophie, et al.
Publicado: (2020)

Association of the Charlson Comorbidity Index with Renal Outcome and All-Cause Mortality in Antineutrophil Cytoplasmatic Antibody-Associated Vasculitis
por: Ofer-Shiber, Shachaf, et al.
Publicado: (2014)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

Autoimmunity and COVID-19 – The microbiotal connection
por: Katz-Agranov, Nurit, et al.
Publicado: (2021)

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review
por: Pires da Rosa, Gilberto, et al.
Publicado: (2022)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Biologic therapy for autoimmune diseases: an update
por: Rosman, Ziv, et al.
Publicado: (2013)

Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations
por: Palli, Eleni, et al.
Publicado: (2019)

Renal Involvement in Antiphospholipid Syndrome
por: Turrent-Carriles, Alonso, et al.
Publicado: (2018)

Complement in the Pathophysiology of the Antiphospholipid Syndrome
por: Chaturvedi, Shruti, et al.
Publicado: (2019)

Unusual manifestations of the antiphospholipid syndrome
por: Asherson, Ronald A., et al.
Publicado: (2003)

Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Gerosa, Maria, et al.
Publicado: (2016)

New Therapeutic Strategies for Systemic Sclerosis—a Critical Analysis of the Literature
por: Zandman-Goddard, Gisele, et al.
Publicado: (2005)

The role of the intestinal microbiome in antiphospholipid syndrome
por: van Mourik, Dagmar J. M., et al.
Publicado: (2022)

An update on the biologics for the treatment of antiphospholipid syndrome
por: Yun, Zelin, et al.
Publicado: (2023)

Recurrent Non-stroke Central Neurologic Manifestations in Primary Antiphospholipid Syndrome
por: You, Hanxiao, et al.
Publicado: (2022)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Neurological manifestations in patients with antiphospholipid syndrome
por: Etemadifar, Masoud, et al.
Publicado: (2013)

Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
por: Leal Rato, Miguel, et al.
Publicado: (2021)

Sudden Cardiac Arrest as the First Manifestation in a Patient with Catastrophic Antiphospholipid Syndrome
por: Sahashi, Yuki, et al.
Publicado: (2020)

Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment
por: Tektonidou, Maria G.
Publicado: (2018)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Exosome-Contained APOH Associated With Antiphospholipid Syndrome
por: Tan, Yuan, et al.
Publicado: (2021)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
por: Álvarez-Rodríguez, Lorena, et al.
Publicado: (2019)

Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome—Multicenter, Real-Life Long-Term Follow-Up
por: Niznik, Stanley, et al.
Publicado: (2022)

Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome
por: Pérez, Dolores, et al.
Publicado: (2018)

Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity
por: Safra, Modi, et al.
Publicado: (2023)

Sirolimus Monotherapy for Thrombocytopenia in Primary Antiphospholipid Syndrome: A Pilot Study From a Tertiary Referral Center
por: Xie, Wenhui, et al.
Publicado: (2022)

Nonarteritic anterior ischemic optic neuropathy as the presenting manifestation of primary antiphospholipid syndrome
por: Tugcu, Betul, et al.
Publicado: (2014)

25. Use of rituximab in refractory primary antiphospholipid syndrome with pulmonary and cerebral manifestations
por: Khan, Asim, et al.
Publicado: (2019)

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vb65h3g7jfnf78k0kevko6mrit